Los Angeles, CA, United States of America

Kambiz Yadidi

This inventor holds 20 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Inhalation Formulations. Top assignees: Otitopic Inc., Vectura Gmbh, Aspeya US Inc.. Active years: 2017-2025. Education: University of Southern California (USA).

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kambiz Yadidi. Retrieved from https://idiyas.com/inventor/kambiz-yadidi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Graduated from:

University of Southern California (USA)

USPTO Granted Patents = 20 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 13)

Average Co-Inventor Count = 1.1

ph-index = 5

Forward Citations = 66(Granted Patents)

Company Filing History:

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Dry Powder Formulations

Inhalation Technologies

Magnesium Stearate

Dry Powder Inhaler

Inflammation Treatment

Nasal Irrigation

Aspirin Compositions

Antibiotic Compositions

Inhaled Medications

Delivery Devices

Formulation Methods

Powder Compositions

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12508227 - Dry powder compositions with magnesium stearate (2025-12-30),

2. 12343425 - Dry powder formulations for inhalation (2025-07-01),

3. 12329899 - Dry powder inhaler and methods of use (2025-06-17),

4. 12144820 - Dry powder formulations for inhalation (2024-11-19),

5. 11865210 - Dry powder formulations and methods of use (2024-01-09),

6. 11819569 - Treating inflammation with inhaled aspirin (2023-11-21),

7. 11596603 - Dry powder formulations for inhalation (2023-03-07),

8. 11160815 - Dry powder formulations for inhalation (2021-11-02),

9. 11077058 - Dry powder compositions with magnesium stearate (2021-08-03),

10. 10849909 - Antibiotic compositions for nasal irrigation and methods (2020-12-01),

11. 10813881 - Dry powder inhalation device (2020-10-27),

12. 10786456 - Inhaled aspirin and magnesium to treat inflammation (2020-09-29),

13. 10772832 - Dry powder formulations for inhalation (2020-09-15),

14. 10568894 - Dry powder formulations for inhalation (2020-02-25),

15. 10420776 - Antibiotic compositions for nasal irrigation and methods (2019-09-24),

Title: Innovator Spotlight: Kambiz Yadidi, the Pioneer in Pulmonary Drug Delivery

Introduction

Kambiz Yadidi, a distinguished inventor in the field of pharmaceuticals, has made significant contributions to pulmonary drug delivery technology. Based in Los Angeles, CA, Kambiz Yadidi holds an impressive portfolio of 16 patents, with a focus on innovative dry powder formulations and methods for treating inflammation using inhaled aspirin.

Latest Patents

Yadidi's latest patents showcase his expertise in pulmonary delivery of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), particularly aspirin. The patents titled "Dry powder formulations and methods of use" and "Treating inflammation with inhaled aspirin" highlight his commitment to developing novel approaches for respiratory drug administration to effectively address inflammatory conditions.

Career Highlights

Having worked with reputable companies such as Otitopic Inc. and Vectura GmbH, Kambiz Yadidi has gained invaluable experience in the pharmaceutical industry. His dedication to advancing pulmonary drug delivery technology has led to the development of groundbreaking solutions that offer new possibilities for the management of respiratory disorders.

Collaborations

Throughout his career, Kambiz Yadidi has collaborated with talented individuals in the field, including coworkers like Amanda Quiroga and Jagdeep Shur. These collaborations have fostered creativity, innovation, and knowledge exchange, further propelling Yadidi's success in developing transformative pharmaceutical products.

Conclusion

In conclusion, Kambiz Yadidi stands out as a pioneering figure in the realm of pulmonary drug delivery, with a remarkable track record of 16 patents that demonstrate his innovative thinking and dedication to improving healthcare outcomes. His contributions to the field continue to inspire advancements in pharmaceutical technology, offering hope for more effective treatments for respiratory diseases.

Profile summary based on public USPTO records.